Kanner Steven 4
4 · Caribou Biosciences, Inc. · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Kanner Steven
Chief Scientific Officer
Transactions
- Exercise/Conversion
Option to purchase Common Stock
2022-12-02$2.69/sh−21,401$57,569→ 52,200 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (21,401 underlying) - Exercise/Conversion
Common Stock
2022-12-02$2.69/sh+21,401$57,569→ 323,460 total
Footnotes (1)
- [F1]1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.